BR112023021963A2 - Sistemas de produção estáveis para produção do vírus adenoassociado - Google Patents
Sistemas de produção estáveis para produção do vírus adenoassociadoInfo
- Publication number
- BR112023021963A2 BR112023021963A2 BR112023021963A BR112023021963A BR112023021963A2 BR 112023021963 A2 BR112023021963 A2 BR 112023021963A2 BR 112023021963 A BR112023021963 A BR 112023021963A BR 112023021963 A BR112023021963 A BR 112023021963A BR 112023021963 A2 BR112023021963 A2 BR 112023021963A2
- Authority
- BR
- Brazil
- Prior art keywords
- associated virus
- production
- stable production
- production systems
- genetically modified
- Prior art date
Links
- 241000702421 Dependoparvovirus Species 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002123 temporal effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
- C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
- C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
sistemas de produção estáveis para produção do vírus adenoassociado. a presente invenção refere-se a células geneticamente modificadas para produção do aav. a célula geneticamente modificada compreende sistemas moleculares para controle temporal da expressão de genes necessários para a produção de aav. também são aqui descritos os métodos de utilização de células geneticamente modificadas para produção do aav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163177760P | 2021-04-21 | 2021-04-21 | |
PCT/US2022/025755 WO2022226189A1 (en) | 2021-04-21 | 2022-04-21 | Stable production systems for adeno-associated virus production |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023021963A2 true BR112023021963A2 (pt) | 2024-01-16 |
Family
ID=83723162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023021963A BR112023021963A2 (pt) | 2021-04-21 | 2022-04-21 | Sistemas de produção estáveis para produção do vírus adenoassociado |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP4326883A1 (pt) |
JP (1) | JP2024515369A (pt) |
KR (1) | KR20240019759A (pt) |
CN (1) | CN117529558A (pt) |
AU (1) | AU2022262365A1 (pt) |
BR (1) | BR112023021963A2 (pt) |
CA (1) | CA3217226A1 (pt) |
IL (1) | IL307830A (pt) |
MX (1) | MX2023012518A (pt) |
WO (1) | WO2022226189A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240101620A (ko) * | 2021-11-09 | 2024-07-02 | 아시모브 인코포레이티드 | Aav 벡터 생산을 위한 안정한 생산 시스템 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU775679B2 (en) * | 1998-08-20 | 2004-08-12 | Cell Genesys, Inc. | Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products |
WO2005080581A2 (en) * | 2004-02-17 | 2005-09-01 | University Of Florida Research Foundation, Inc. | Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
WO2010114948A2 (en) * | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors |
AU2013320184B2 (en) * | 2012-09-24 | 2017-10-12 | Medimmune Limited | Cell lines |
US11702673B2 (en) * | 2018-10-18 | 2023-07-18 | University Of Florida Research Foundation, Incorporated | Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus |
EP3870148A4 (en) * | 2018-10-25 | 2022-11-09 | Takeda Pharmaceutical Company Limited | AAV TRIPLE PLASMID SYSTEM |
US20220290121A1 (en) * | 2019-08-30 | 2022-09-15 | The General Hospital Corporation | Combinatorial Adenine and Cytosine DNA Base Editors |
AU2020361533A1 (en) * | 2019-10-08 | 2022-04-28 | Trustees Of Boston College | Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins |
-
2022
- 2022-04-21 IL IL307830A patent/IL307830A/en unknown
- 2022-04-21 WO PCT/US2022/025755 patent/WO2022226189A1/en active Application Filing
- 2022-04-21 MX MX2023012518A patent/MX2023012518A/es unknown
- 2022-04-21 CN CN202280044018.4A patent/CN117529558A/zh active Pending
- 2022-04-21 BR BR112023021963A patent/BR112023021963A2/pt unknown
- 2022-04-21 JP JP2023565269A patent/JP2024515369A/ja active Pending
- 2022-04-21 CA CA3217226A patent/CA3217226A1/en active Pending
- 2022-04-21 AU AU2022262365A patent/AU2022262365A1/en active Pending
- 2022-04-21 EP EP22792495.8A patent/EP4326883A1/en active Pending
- 2022-04-21 KR KR1020237039938A patent/KR20240019759A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
AU2022262365A1 (en) | 2023-11-09 |
CA3217226A1 (en) | 2022-10-27 |
EP4326883A1 (en) | 2024-02-28 |
WO2022226189A1 (en) | 2022-10-27 |
MX2023012518A (es) | 2024-02-08 |
KR20240019759A (ko) | 2024-02-14 |
JP2024515369A (ja) | 2024-04-09 |
IL307830A (en) | 2023-12-01 |
CN117529558A (zh) | 2024-02-06 |
AU2022262365A9 (en) | 2023-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112023021963A2 (pt) | Sistemas de produção estáveis para produção do vírus adenoassociado | |
BR112015028493A2 (pt) | Métodos para preparar células t para imunoterapia, célula t isolada, seu uso e composição farmacêutica | |
CO2019004006A2 (es) | Método para incrementar los niveles de secreción de la interleucina 2 y sus proteínas derivadas | |
BR112014026206A2 (pt) | sistemas e métodos celulares para melhorar a síntese de ácidos graxos através da expressão da desidrogenase | |
RU2014104677A (ru) | Рекомбинантный микроорганизм для получения полезных метаболитов | |
BR112012016320B8 (pt) | Método para tratar material celulósico, polipeptídeo, molécula de ácido nucleico isolada, vetor de expressão recombinante, célula hospedeira, processos para produzir um polipeptídeo, e para obter uma preparação de enzima, preparação de enzima, e, uso do polipeptídeo ou da preparação de enzima | |
BR112015019603A2 (pt) | Moléculas de ácido nucleico isoladas, molécula de polipeptídeo isolada, molécula isolada de car, domínio de ligação anti-egfrviii, vetor, célula e uso de uma quantidade eficaz da mesma e métodos para produção de uma célula e para a produção de uma população de células modificadas por rna | |
BR112021025359A2 (pt) | Composições de proteína anti-vegf e métodos para a produção das mesmas | |
BRPI0513706A (pt) | anticorpo policlonal recombinante anti-rhesus d e métodos de produção | |
BR112018017194A2 (pt) | vetor, célula cancerosa ou célula imune, e, medicamento. | |
BR112022011904A2 (pt) | Produção de oligossacarídeo sialilado em células hospedeiras | |
CL2022001679A1 (es) | Células de levadura y métodos para la producción de e8,e10-dodecadienil coenzima a, codlemona y derivados | |
BR112023002395A2 (pt) | Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna) | |
PE20211110A1 (es) | Distrofinas miniaturizadas y usos de las mismas | |
BR112022013940A2 (pt) | Receptores de antígenos quiméricos para eliminação de amiloides | |
BR112022012105A2 (pt) | Variantes de xilanase e polinucleotídeos codificando as mesmas | |
BR112021026326A2 (pt) | Sacarose fosforilase engenheirada, composição, sequência de polinucleotídeo, vetor de expressão, célula hospedeira, e, método para produzir uma sacarose fosforilase engenheirada | |
BR112018014639A2 (pt) | expressão de múltiplos genes em microalgas | |
BR112022019167A2 (pt) | Inteínas split e usos das mesmas | |
BR112017018030A2 (pt) | variante de celobiohidrolase, polinucleotídeo isolado, célula hospedeira recombinante, método para produção de uma variante de celobiohidrolase, composição de enzima inteiro ou composição de cultura de células, e, processos para degradação de um material celulósico, para produção de um produto de fermentação e para fermentação de um material celulósico | |
BR112016006560A2 (pt) | molécula de ácido nucleico sintética, gene quimérico, vetor, método de transformação de células bacterianas, linhagem bacteriana recombinante, método de produção de promotores de gene e promotor de gene | |
BR112014015566B8 (pt) | Célula hospedeira bacteriana recombinante e processo para produção de etanol | |
BR112014019578A2 (pt) | Proteína, molécula de dna, células eucarióticase de levedura geneticamente modificada, usos de proteína, de molécula de dna e de células eucarióticas e processos de produção de etanol e de geração de produto de fermentação | |
BR112017003074A2 (pt) | Célula isolada, e, métodos de produção de uma proteína recombinante de interesse e de glicosilação de um substrato de proteína de n- glicano. | |
BR112023003468A2 (pt) | Variantes de uma xiloglucanase da família 44 |